Jazz Pharmaceuticals plc financial data

Symbol
JAZZ on Nasdaq
Location
Fifth Floor, Waterloo Exchange, Waterloo Road, Dublin, Ireland
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 240 % -9.29%
Quick Ratio 29.7 % -25.2%
Return On Assets -3.21 % -180%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 60.8M shares +0.51%
Common Stock, Shares, Outstanding 60.6M shares -2.61%
Entity Public Float 6.41B USD -16.3%
Common Stock, Value, Issued 6K USD 0%
Weighted Average Number of Shares Outstanding, Basic 60.7M shares -1.17%
Weighted Average Number of Shares Outstanding, Diluted 61.6M shares -2.48%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 4.16B USD +4.14%
Costs and Expenses 4.65B USD +39.1%
Operating Income (Loss) -494M USD -176%
Income Tax Expense (Benefit) -335M USD -403%
Net Income (Loss) Attributable to Parent -368M USD -180%
Earnings Per Share, Basic -6 USD/shares -181%
Earnings Per Share, Diluted -6 USD/shares -188%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.33B USD -40.2%
Accounts Receivable, after Allowance for Credit Loss, Current 764M USD +5.63%
Inventory, Net 483M USD -10.4%
Other Assets, Current 315M USD -10.9%
Assets, Current 3.76B USD -14.5%
Deferred Income Tax Assets, Net 846M USD +45.1%
Operating Lease, Right-of-Use Asset 61.2M USD -20.7%
Intangible Assets, Net (Excluding Goodwill) 4.57B USD -11.2%
Goodwill 1.83B USD +1.27%
Other Assets, Noncurrent 103M USD +37%
Assets 11.4B USD -7.34%
Accounts Payable, Current 152M USD +78.2%
Accrued Liabilities, Current 1B USD +16.7%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 2.27B USD +121%
Deferred Income Tax Liabilities, Net 629M USD -20.6%
Operating Lease, Liability, Noncurrent 53.4M USD -24.9%
Other Liabilities, Noncurrent 109M USD -1.86%
Accumulated Other Comprehensive Income (Loss), Net of Tax -570M USD +5.55%
Retained Earnings (Accumulated Deficit) 443M USD -52.7%
Stockholders' Equity Attributable to Parent 3.96B USD -5.08%
Liabilities and Equity 11.4B USD -7.34%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 430M USD +60.8%
Net Cash Provided by (Used in) Financing Activities -813M USD -1338%
Net Cash Provided by (Used in) Investing Activities -169M USD +37.9%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 60.6M shares -2.61%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -551M USD -776%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.33B USD -40.2%
Deferred Tax Assets, Valuation Allowance 509M USD +63%
Deferred Tax Assets, Gross 1.58B USD +19.1%
Operating Lease, Liability 53.3M USD -31.9%
Depreciation 10.4M USD +36.2%
Payments to Acquire Property, Plant, and Equipment 13.9M USD +101%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -335M USD -137%
Lessee, Operating Lease, Liability, to be Paid 62.9M USD -30.5%
Operating Lease, Liability, Current 14.3M USD -24.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 12.6M USD -25.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 16.6M USD -27.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure +18.5%
Deferred Income Tax Expense (Benefit) -43.8M USD +34%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 9.62M USD -21%
Lessee, Operating Lease, Liability, to be Paid, Year Three 10.3M USD -27.3%
Deferred Tax Assets, Operating Loss Carryforwards 307M USD +3.68%
Unrecognized Tax Benefits 126M USD +2.68%
Lessee, Operating Lease, Liability, to be Paid, Year Four 9.02M USD -28.8%
Amortization of Intangible Assets 644M USD +3.85%
Deferred Tax Assets, Net of Valuation Allowance 1.07B USD +5.57%
Share-based Payment Arrangement, Expense 290M USD +25.9%